Clinical trial shows CRISPR gene editing has exciting potential to treat a rare form of blindness

  • Post author:
  • Post category:uncategorized

A recent study published in The New England Journal of Medicine investigated the potential use of gene editing to correct a congenital retinal degeneration called CEP290 that causes early-onset vision loss.